Skip to Content

Elekta AB Class B EKTA B

Morningstar Rating
SEK 67.35 −0.50 (0.74%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

EKTA B is trading at a 13% premium.
Price
SEK 67.85
Fair Value
SEK 766.00
Uncertainty
Medium
1-Star Price
SEK 851.68
5-Star Price
SEK 26.70
Economic Moat
Dbf
Capital Allocation
Fvxdyvh

Bulls Say, Bears Say

Bulls

We estimate that the Asia-Pacific marketplace could support up to 5,000 additional linac installations. Given Elekta's strong ties with emerging-market customers, particularly in China, we believe the company can grab a sizable portion of greenfield in this region.

Bears

GenesisCare order book in the U.S. has been written down, dealing another blow to the company's U.S. plans.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EKTA B is a good fit for your portfolio.

Trading Information

Previous Close Price
SEK 67.85
Day Range
SEK 67.1568.00
52-Week Range
SEK 64.0090.00
Bid/Ask
SEK 67.25 / SEK 67.35
Market Cap
SEK 25.73 Bil
Volume/Avg
217,335 / 1.3 Mil

Key Statistics

Price/Earnings (Normalized)
16.28
Price/Sales
1.43
Dividend Yield (Trailing)
3.54%
Dividend Yield (Forward)
3.54%
Total Yield
3.54%

Company Profile

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,000 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and the Asia-Pacific contributing the remainder.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Growth
Total Number of Employees
4,607

Competitors

Valuation

Metric
EKTA B
ISRG
BDX
Price/Earnings (Normalized)
16.2872.7318.91
Price/Book Value
2.4111.142.60
Price/Sales
1.4321.893.41
Price/Cash Flow
9.7257.2518.86
Price/Earnings
EKTA B
ISRG
BDX

Financial Strength

Metric
EKTA B
ISRG
BDX
Quick Ratio
0.694.030.78
Current Ratio
1.005.151.41
Interest Coverage
4.244.31
Quick Ratio
EKTA B
ISRG
BDX

Profitability

Metric
EKTA B
ISRG
BDX
Return on Assets (Normalized)
4.53%14.89%3.59%
Return on Equity (Normalized)
13.61%17.17%7.46%
Return on Invested Capital (Normalized)
9.82%15.09%5.23%
Return on Assets
EKTA B
ISRG
BDX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
NtxmkcwljgYqvy$163.9 Bil
Becton Dickinson & Co
BDX
PkyfqrxpCnthjm$66.8 Bil
Alcon Inc
ALC
HzwzvgsvjKztyt$44.6 Bil
ResMed Inc
RMD
JmqbkwyfpLxhzkys$30.5 Bil
Coloplast A/S ADR
CLPBY
VhyjpxwhgWwls$28.9 Bil
West Pharmaceutical Services Inc
WST
SdpcsnpwvSyz$23.3 Bil
Hologic Inc
HOLX
GfchvwzdYqrrtkv$18.3 Bil
The Cooper Companies Inc
COO
ZrjnnzmqRqgfltw$18.2 Bil
Baxter International Inc
BAX
XthsvlfYjklbpk$18.0 Bil
Teleflex Inc
TFX
DmgnLryhp$10.5 Bil

Sponsor Center